{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:07:09Z","timestamp":1775516829654,"version":"3.50.1"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2024,3,25]]},"DOI":"10.1253\/circj.cj-23-0777","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T22:12:32Z","timestamp":1707343952000},"page":"519-527","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Native T&lt;sub&gt;1&lt;\/sub&gt; Mapping for Patients With Non-Ischemic Cardiomyopathy and Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair"],"prefix":"10.1253","volume":"88","author":[{"given":"Hiroshi","family":"Tsunamoto","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"},{"name":"Department of Exploratory and Advanced Search in Cardiology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Masumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyo","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Hyogo Prefectural Harima-Himeji General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuari","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"},{"name":"Department of Exploratory and Advanced Search in Cardiology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center"},{"name":"Department of Exploratory and Advanced Search in Cardiology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. <i>Circulation<\/i> 2001; 103: 1759\u20131764.","DOI":"10.1161\/01.CIR.103.13.1759"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Trichon BH, Felker GM, Shaw LK, Cabell CH, O\u2019Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. <i>Am J Cardiol<\/i> 2003; 91: 538\u2013543.","DOI":"10.1016\/S0002-9149(02)03301-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bursi F, Barbieri A, Grigioni F, Reggianini L, Zanasi V, Leuzzi C, et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: A long-term outcome study. <i>Eur J Heart Fail<\/i> 2010; 12: 382\u2013388.","DOI":"10.1093\/eurjhf\/hfq014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure: A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. <i>Heart<\/i> 2011; 97: 1675\u20131680.","DOI":"10.1136\/hrt.2011.225789"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. <i>J Am Coll Cardiol<\/i> 2015; 66: 2844\u20132854.","DOI":"10.1016\/j.jacc.2015.10.018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Grover FL, Vemulapalli S, Carroll JD, Edwards FH, Mack MJ, Thourani VH, et al. 2016 Annual report of the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry. <i>J Am Coll Cardiol<\/i> 2017; 69: 1215\u20131230.","DOI":"10.1016\/j.jacc.2016.11.033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>Circulation<\/i> 2022; 145: e895\u2013e1032.","DOI":"10.1161\/CIR.0000000000001073"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. <i>N Engl J Med<\/i> 2018; 379: 2297\u20132306.","DOI":"10.1056\/NEJMoa1805374"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. <i>N Engl J Med<\/i> 2018; 379: 2307\u20132318.","DOI":"10.1056\/NEJMoa1806640"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shah RV, Kato S, Roujol S, Murthy V, Bellm S, Kashem A, et al. Native myocardial T1 as a biomarker of cardiac structure in non-ischemic cardiomyopathy. <i>Am J Cardiol<\/i> 2016; 117: 282\u2013288.","DOI":"10.1016\/j.amjcard.2015.10.046"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li S, Zhou D, Sirajuddin A, He J, Xu J, Zhuang B, et al. T1 mapping and extracellular volume fraction in dilated cardiomyopathy: A prognosis study. <i>JACC Cardiovasc Imaging<\/i> 2022; 15: 578\u2013590.","DOI":"10.1016\/j.jcmg.2021.07.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. <i>Eur Heart J<\/i> 2022; 43: 561\u2013632.","DOI":"10.1093\/ejcts\/ezac209"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). <i>J Cardiovasc Magn Reson<\/i> 2018; 20: 9.","DOI":"10.1186\/s12968-017-0408-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C. European Association of Cardiovascular Imaging expert consensus paper: A comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. <i>Eur Heart J Cardiovasc Imaging<\/i> 2019; 20: 1321\u20131331.","DOI":"10.1093\/ehjci\/jez232"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease--The ConSept study. <i>J Cardiovasc Magn Reson<\/i> 2013; 15: 78.","DOI":"10.1186\/1532-429X-15-78"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kellman P, Hansen MS. T1-mapping in the heart: Accuracy and precision. <i>J Cardiovasc Magn Reson<\/i> 2014; 16: 2.","DOI":"10.1186\/1532-429X-16-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 233\u2013270.","DOI":"10.1093\/ehjci\/jev014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: A new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials. <i>JACC Cardiovasc Imaging<\/i> 2019; 12: 353\u2013362.","DOI":"10.1016\/j.jcmg.2018.11.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Medvedofsky D, Milhorini Pio S, Weissman NJ, Namazi F, Delgado V, Grayburn PA, et al. Left ventricular global longitudinal strain as a predictor of outcomes in patients with heart failure with secondary mitral regurgitation: The COAPT trial. <i>J Am Soc Echocardiogr<\/i> 2021; 34: 955\u2013965.","DOI":"10.1016\/j.echo.2021.04.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mizote I, Nakamura D. Who benefits from the MitraClip? <i>Circ J<\/i> 2022; 86: 412\u2013414.","DOI":"10.1253\/circj.CJ-21-0924"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: Lessons from two trials with diametrically opposed results. <i>Eur Heart J Cardiovasc Imaging<\/i> 2019; 20: 620\u2013624.","DOI":"10.1093\/ehjci\/jez073"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Braun J, van de Veire NR, Klautz RJ, Versteegh MI, Holman ER, Westenberg JJ, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. <i>Ann Thorac Surg<\/i> 2008; 85: 430\u2013436; discussion 436\u2013437.","DOI":"10.1016\/j.athoracsur.2007.08.040"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. <i>Eur J Cardiothorac Surg<\/i> 2005; 27: 847\u2013853.","DOI":"10.1016\/j.ejcts.2004.12.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Cadour F, Quemeneur M, Biere L, Donal E, Bentatou Z, Eicher JC, et al. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. <i>J Cardiovasc Magn Reson<\/i> 2023; 25: 7.","DOI":"10.1186\/s12968-023-00919-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker Imaging (MOLLI) T1 mapping at 3 T. <i>J Cardiovasc Magn Reson<\/i> 2015; 17: 48.","DOI":"10.1186\/s12968-015-0150-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kitkungvan D, Yang EY, El Tallawi KC, Nagueh SF, Nabi F, Khan MA, et al. Extracellular volume in primary mitral regurgitation. <i>JACC Cardiovasc Imaging<\/i> 2021; 14: 1146\u20131160.","DOI":"10.1016\/j.jcmg.2020.10.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Liu B, Neil DAH, Premchand M, Bhabra M, Patel R, Barker T, et al. Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance. <i>J Cardiovasc Magn Reson<\/i> 2020; 22: 86.","DOI":"10.1186\/s12968-020-00674-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Elming MB, Hammer-Hansen S, Voges I, Nyktari E, Raja AA, Svendsen JH, et al. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI. <i>Am Heart J<\/i> 2020; 221: 165\u2013176.","DOI":"10.1016\/j.ahj.2019.10.020"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. <i>Circulation<\/i> 2017; 135: 2106\u20132115.","DOI":"10.1161\/CIRCULATIONAHA.116.026910"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2006; 48: 1977\u20131985.","DOI":"10.1016\/j.jacc.2006.07.049"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takahashi EA, Kallmes DF, Mara KC, Harmsen WS, Misra S. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: Retrospective analysis with 10-year follow-up. <i>Diagn Interv Radiol<\/i> 2018; 24: 378\u2013384.","DOI":"10.5152\/dir.2018.18172"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. Use of intravenous gadolinium-based contrast media in patients with kidney disease: Consensus statements from the American College of Radiology and the National Kidney Foundation. <i>Radiology<\/i> 2021; 298: 28\u201335.","DOI":"10.1148\/radiol.2020202903"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/4\/88_CJ-23-0777\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:51:57Z","timestamp":1715575917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/4\/88_CJ-23-0777\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-23-0777","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"article-number":"CJ-23-0777"}}